MEDNATION AG (EIF.DE) Stock Fundamental Analysis
Europe - FRA:EIF - DE0005653604 - Common Stock
2.94 EUR
+0.14 (+5%)
Taking everything into account, EIF scores 3 out of 10 in our fundamental rating. EIF was compared to 31 industry peers in the Health Care Providers & Services industry. EIF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EIF has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year EIF was profitable.
In the past year EIF had a positive cash flow from operations.
In multiple years EIF reported negative net income over the last 5 years.
In the past 5 years EIF always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of EIF (0.29%) is worse than 77.42% of its industry peers.
EIF's Return On Equity of 0.90% is on the low side compared to the rest of the industry. EIF is outperformed by 80.65% of its industry peers.
EIF has a Return On Invested Capital of 2.01%. This is amonst the worse of the industry: EIF underperforms 80.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EIF is below the industry average of 6.26%.
The 3 year average ROIC (1.75%) for EIF is below the current ROIC(2.01%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.29% | ||
| ROE | 0.9% | ||
| ROIC | 2.01% |
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 0.21%, EIF is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
Looking at the Operating Margin, with a value of 2.95%, EIF is doing worse than 64.52% of the companies in the same industry.
In the last couple of years the Operating Margin of EIF has declined.
The Gross Margin of EIF (90.58%) is better than 93.55% of its industry peers.
In the last couple of years the Gross Margin of EIF has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.95% | ||
| PM (TTM) | 0.21% | ||
| GM | 90.58% |
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
2. Health
2.1 Basic Checks
EIF has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EIF has been reduced compared to 1 year ago.
The number of shares outstanding for EIF has been reduced compared to 5 years ago.
The debt/assets ratio for EIF has been reduced compared to a year ago.
2.2 Solvency
EIF has an Altman-Z score of 1.86. This is not the best score and indicates that EIF is in the grey zone with still only limited risk for bankruptcy at the moment.
EIF has a Altman-Z score (1.86) which is comparable to the rest of the industry.
EIF has a debt to FCF ratio of 8.55. This is a slightly negative value and a sign of low solvency as EIF would need 8.55 years to pay back of all of its debts.
EIF has a Debt to FCF ratio (8.55) which is comparable to the rest of the industry.
EIF has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of EIF (1.06) is worse than 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 8.55 | ||
| Altman-Z | 1.86 |
ROIC/WACC0.48
WACC4.23%
2.3 Liquidity
EIF has a Current Ratio of 1.57. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
EIF has a Current ratio of 1.57. This is in the better half of the industry: EIF outperforms 77.42% of its industry peers.
EIF has a Quick Ratio of 1.38. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.38, EIF belongs to the best of the industry, outperforming 83.87% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
EIF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.94%.
The Revenue has been growing slightly by 7.56% in the past year.
Measured over the past years, EIF shows a small growth in Revenue. The Revenue has been growing by 0.13% on average per year.
EPS 1Y (TTM)-85.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.57%
Revenue 1Y (TTM)7.56%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%3.33%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 147.00, the valuation of EIF can be described as expensive.
EIF's Price/Earnings ratio is rather expensive when compared to the industry. EIF is more expensive than 80.65% of the companies in the same industry.
EIF is valuated expensively when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 147 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EIF indicates a rather cheap valuation: EIF is cheaper than 80.65% of the companies listed in the same industry.
77.42% of the companies in the same industry are more expensive than EIF, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.36 | ||
| EV/EBITDA | 6.74 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
EIF does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EIF (10/16/2025, 7:00:00 PM)
2.94
+0.14 (+5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.13%
Ins Owner ChangeN/A
Market Cap9.17M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 147 | ||
| Fwd PE | N/A | ||
| P/S | 0.19 | ||
| P/FCF | 6.36 | ||
| P/OCF | 3.97 | ||
| P/B | 0.79 | ||
| P/tB | 0.79 | ||
| EV/EBITDA | 6.74 |
EPS(TTM)0.02
EY0.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.46
FCFY15.72%
OCF(TTM)0.74
OCFY25.22%
SpS15.63
BVpS3.71
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.29% | ||
| ROE | 0.9% | ||
| ROCE | 4.73% | ||
| ROIC | 2.01% | ||
| ROICexc | 2.23% | ||
| ROICexgc | 2.23% | ||
| OM | 2.95% | ||
| PM (TTM) | 0.21% | ||
| GM | 90.58% | ||
| FCFM | 2.96% |
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)1.97%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y6.43%
ROICexc growth 3YN/A
ROICexc growth 5Y6.41%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
F-Score7
Asset Turnover1.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 8.55 | ||
| Debt/EBITDA | 4.48 | ||
| Cap/Depr | 66.39% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 84.1% | ||
| Profit Quality | 1378.59% | ||
| Current Ratio | 1.57 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 1.86 |
F-Score7
WACC4.23%
ROIC/WACC0.48
Cap/Depr(3y)35.94%
Cap/Depr(5y)25.78%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.56%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%3.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.59%
EBIT growth 3YN/A
EBIT growth 5Y-8.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y134.09%
FCF growth 3Y-18.54%
FCF growth 5Y-3.22%
OCF growth 1Y133.4%
OCF growth 3Y-13.99%
OCF growth 5Y-5.06%